The role cancer-derived exosomes play on the modulation of bone marrow mesenchymal stromal cells has been previously studied in a neuroblastoma model, and ERK1/2 described to control the level of IL-6 and IL-8/CXCL8 (44). The gene discussed is IL6; the disease is cancer.